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Abstract
Introduction Body mass index (BMI) during adulthood is
inversely related to the incidence of premenopausal breast
cancer, but the role of body fatness earlier in life is less clear.
We examined prospectively the relation between body fatness
during childhood and adolescence and the incidence of breast
cancer in premenopausal women.
Methods Participants were 109,267 premenopausal women in
the Nurses' Health Study II who recalled their body fatness at
ages 5, 10 and 20 years using a validated 9-level figure drawing.
Over 12 years of follow up, 1318 incident cases of breast
cancer were identified. Cox proportional hazards regression
was used to compute relative risks (RRs) and 95% confidence
intervals (CIs) for body fatness at each age and for average
childhood (ages 5–10 years) and adolescent (ages 10–20
years) fatness.
Results Body fatness at each age was inversely associated with
premenopausal breast cancer incidence; the multivariate RRs
were 0.48 (95% CI 0.35–0.55) and 0.57 (95% CI 0.39–0.83)
for the most overweight compared with the most lean in
childhood and adolescence, respectively (P for trend < 0.0001).
The association for childhood body fatness was only slightly
attenuated after adjustment for later BMI, with a multivariate RR
of 0.52 (95% CI 0.38–0.71) for the most overweight compared
with the most lean (P  for trend = 0.001). Adjustment for
menstrual cycle characteristics had little impact on the
association.
Conclusion Greater body fatness during childhood and
adolescence is associated with reduced incidence of
premenopausal breast cancer, independent of adult BMI and
menstrual cycle characteristics.
Introduction
Body mass index (BMI) during adulthood is related to breast
cancer incidence, although the direction of the association
varies by menopausal status. More overweight women have a
lower risk of breast cancer before menopause but a higher risk
after menopause [1,2]. In premenopausal women, greater adi-
posity may increase the frequency of anovulatory menstrual
cycles, thus reducing exposure to ovarian hormones [3]. In
contrast, greater adiposity in postmenopausal women
increases both estrogen levels and breast cancer risk, which
is probably due to the conversion of androgens to estrone in
adipose tissue [3].
BMI = body mass index; CI = confidence interval; RR = relative risk.Breast Cancer Research    Vol 7 No 3    Baer et al.
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Despite the consistency of evidence for adult BMI, few studies
have examined the role of body fatness during childhood and
early adolescence, and results have been inconclusive. The
majority have been case-control studies in which body fatness
at young ages was recalled after diagnosis of breast cancer.
Some [4-7] but not all [8-11] of these studies have shown
inverse associations between body fatness at young ages and
breast cancer risk. In a study that linked census records for
residents of Hawaii to tumor registry data [12], a strong
inverse association was seen between prospectively recorded
body fatness from ages 10–14 years and incidence of pre-
menopausal breast cancer; a study conducted in Finland that
used height and weight measurements for ages 7–15 years
from school health records [13] yielded similar findings. How-
ever, limited information on potential confounders was availa-
ble in these studies. In an analysis that combined retrospective
and prospective data within the earlier Nurses' Health Study
[14], inverse associations were observed for recalled body fat-
ness at ages 5, 10, and 20 years in relation to incidence of
both premenopausal and postmenopausal breast cancer, with
the strongest inverse association of these three for body fat-
ness at age 10 years. A prospective cohort study conducted
in Norway and Sweden [15] found inverse associations of per-
ceived body shape at age 7 years and BMI at age 18 years
with incidence of premenopausal breast cancer, but these
associations were attenuated and no longer significant when
adjusted for BMI at enrollment. A recent Danish study that
used information from school health records [16] also found a
modest inverse association between BMI at age 14 years and
breast cancer risk, although no data on adult BMI were
available.
A variety of evidence points to the importance of early life fac-
tors in the etiology of breast cancer. Studies of mammary
gland development in rats have shown that developing breast
tissue may be most vulnerable to carcinogens before the first
birth, when undifferentiated cells are undergoing rapid prolifer-
ation [17,18]. Epidemiologic studies conducted in humans
and biomathematical models also suggest that the years
between menarche and first birth may be a critical time period
for breast carcinogenesis [19]. In light of these findings, it is
plausible that body fatness at young ages could influence risk
of breast cancer later in life.
We examined prospectively the relation between body fatness
during childhood and adolescence and incidence of breast
cancer among premenopausal women in the Nurses' Health
Study II (NHS II). In addition, we investigated whether this rela-
tion is independent of characteristics of the menstrual cycle
and BMI during adulthood.
Materials and methods
Study design and population
The NHS II is a prospective cohort study that began in 1989,
when 116,671 female registered nurses between the ages of
25 and 42 years completed a mailed, self-administered ques-
tionnaire about their health behaviors, lifestyle factors, and
medical histories. Follow-up questionnaires have been sent to
participants every 2 years to obtain updated information on
risk factors and disease diagnoses, and the response rate for
each biennial questionnaire has been greater than 90%.
Deaths are reported by family members and the postal service,
and regular searches of the computerized National Death
Index are also conducted [20]. This analysis includes the
109,267 premenopausal women who provided information on
their body fatness at ages 5, 10, and 20 years on the initial
questionnaire in 1989 and who had no history of cancer (other
than nonmelanoma skin cancer). The study was approved by
human research committees at the Harvard School of Public
Health and Brigham and Women's Hospital.
Ascertainment of breast cancer cases
On each of the biennial questionnaires between 1989 and
2001, participants were asked whether they had been diag-
nosed with breast cancer during the previous 2 years or since
the last questionnaire they returned. Study physicians then
confirmed the self-reported diagnoses by reviewing partici-
pants' medical records and/or pathology reports.
A total of 1318 cases of breast cancer (1044 invasive, 274 in
situ) were reported and subsequently confirmed among eligi-
ble participants during 12 years of follow-up, from 1989 to 1
June 2001. Because epidemiologic studies have generally
shown similar risk factors for in situ and invasive breast cancer
[21-23], both are included in our primary analyses, although
secondary analyses in which the outcome was restricted to
invasive disease were also conducted.
Assessment of body fatness at young ages
In 1989, NHS II participants recalled their body fatness at
ages 5, 10, and 20 years using a 9-level figure drawing (Fig.
1) originally developed by Stunkard and colleagues [24]. Par-
ticipants who did not report their body fatness at one or more
of these ages were excluded. To obtain estimates of childhood
and adolescent body fatness, we averaged each participant's
figures at ages 5 and 10 years (childhood) and at ages 10 and
20 years (adolescence); the goal of this approach was to
reduce the effects of random error in the assessment of body
fatness. Changes in body fatness between ages 5 and 10
years, between ages 10 and 20 years, and between ages 5
and 20 years were also calculated by subtracting each partic-
ipant's figure (levels 1 through 9) at the younger age from that
at the older age.
Must and colleagues [25] evaluated the validity of remote
recall of body fatness among 181 participants in the Third Har-
vard Growth Study, a longitudinal study of physical and mental
growth in children that was conducted between 1922 and
1935 in the Boston area. Height and weight were measured
as part of annual examinations during childhood and adoles-Available online http://breast-cancer-research.com/content/7/3/R314
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cence and were used to calculate BMI in kg/m2. In 1988 and
1989, when participants were between ages 71 and 76 years,
they were interviewed again and asked to recall their body fat-
ness at ages 5, 10, 15, and 20 years, using the same 9-level
figure drawing as that on the 1989 NHS II questionnaire.
Pearson correlations between recalled body fatness and BMI
at approximately the same ages were 0.60 for age 5 years,
0.70 for age 10 years, 0.75 for age 15 years, and 0.66 for age
20 years. Other studies have yielded similar findings [26-29],
indicating that these figure drawings can provide a reasonably
accurate assessment of body fatness at young ages.
Among participants in the Third Harvard Growth Study, which
provides the best available 'gold standard' for the interpreta-
tion of the figure drawing, the median values for BMI from
measured height and weight at age 15 years according to
recalled figure at age 15 years were 19, 19.5, 24, 25, 25.5,
30, and 32 kg/m2 for levels 1 through 7, respectively [25]; no
participants reported being greater than level 7. In the present
study, the median values for BMI at age 18 years (based on
self-reported data) according to recalled figure at age 20
years were 18.1 for level 1, 19.1 for level 2, 20.5 for level 3,
22.3 for level 4, 24.9 for level 5, 28.2 for level 6, 32.0 for level
7, 34.7 for level 8, and 37.8 kg/m2 for level 9.
Assessment of other risk factors
Information on other established and hypothesized breast can-
cer risk factors was collected at various points during the
course of the study. Age, menopausal status, reproductive his-
tory, oral contraceptive use, smoking status, and diagnosis of
benign breast disease were reported at baseline in 1989 and
updated on each of the biennial questionnaires. History of
breast cancer in a first-degree relative (mother or sister) was
reported in 1989 and updated in 1997. Recent alcohol con-
sumption was assessed on the initial questionnaire in 1989
and again in 1991, 1995, and 1999 from semiquantitative
food frequency questionnaires, which also evaluated other
dietary factors. Participation in physical activity was evaluated
in 1989, 1991, and 1997. Height, alcohol consumption
between ages 15 and 17 years and ages 18 and 22 years, and
strenuous physical activity during high school and between
ages 18 and 22 years were assessed in 1989. Other early life
factors such as birthweight and being breastfed as an infant
were reported on the 1991 questionnaire. A subset of partici-
pants (n = 43,317) provided information on dietary factors
during adolescence by completing a supplementary question-
naire on high school diet in 1998.
Weight at age 18 years was reported in 1989, and current
weight was reported on each of the biennial questionnaires;
these were used with height to calculate BMI at age 18 years
and current BMI. Age at menarche, time from menarche until
onset of regular menstrual cycles, and cycle regularity and
length during high school and between ages 18 and 22 years
were reported on the 1989 questionnaire, and recent men-
strual cycle characteristics were reported in 1993.
Analysis
Participants contributed person-time from the return date of
the 1989 questionnaire until the report of breast cancer or
other cancer (except nonmelanoma skin cancer), menopause,
death, or the end of follow-up on 1 June 2001. Cases and per-
son-time were assigned to the appropriate level of body fat-
ness at each age and other risk factors. For time-varying
covariates such as oral contraceptive use and parity, person-
time was re-assigned every 2 years.
Breast cancer incidence rates for each level of body fatness at
ages 5, 10, and 20 years, and during childhood and adoles-
cence were calculated as the number of breast cancer cases
divided by the total number of person-years at each level. Few
participants recalled their body fatness as greater than level 5
at ages 5 and 10 years; for example, for body fatness at age
10 years, 9.1% of participants recalled their figure as level 5,
2.6% recalled their figure as level 6, 0.4% recalled their figure
as level 7, and only 0.1% recalled their figure as either level 8
or level 9. For this reason, figures 5 through 9 were combined
into a single category for most analyses, and similar categories
were created for childhood and adolescent body fatness. Rel-
ative risks (RRs) were calculated by taking the ratio of the inci-
dence rate for each level compared with the lowest level,
which was used as the referent category.
Cox proportional hazards regression was used to estimate
multivariate RRs and 95% confidence intervals (CIs) for body
fatness at young ages while adjusting for age, time period, and
other covariates. Body fatness at each age was examined in a
separate Cox model, because recalled figures at these ages
are highly correlated with one another. Indicator variables were
used to obtain RRs for levels of body fatness at each age, and
tests for linear trend were conducted by entering body fatness
at each age into a Cox model as an ordinal variable with values
Figure 1
Figure drawing [24] used to assess body fatness at different ages  among Nurses' Health Study II participants Figure drawing 24 used to assess body fatness at different ages 
among Nurses' Health Study II participants.Breast Cancer Research    Vol 7 No 3    Baer et al.
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1 through 5. Changes in body fatness between ages 5, 10,
and 20 years were also examined in Cox models, using the
categories decreased, no change, increased 1 level, and
increased 2 or more levels, with no change being the referent
category.
Because BMI during adulthood and menstrual cycle charac-
teristics could be intermediate factors on the pathway from
body fatness at young ages to breast cancer, these were con-
sidered separately from other covariates. To determine
whether the association between body fatness at young ages
and breast cancer is independent of later BMI, we adjusted for
later BMI using several different variables, included in separate
models: BMI at age 18 years, current BMI (updated every 2
years), and the cumulative average of BMI at age 18 years and
all subsequent BMI reports up until the current time period.
These variables were each divided into five categories (not
including those who were missing) and included as continu-
ous terms by assigning the median value of each category.
Childhood body fatness and body fatness at age 20 years
Table 1
Characteristics of 109,267 premenopausal Nurses' Health Study II participants in 1989 according to body fatness at age 10 years
Characteristic Figure at age 10 years
1234≥  5
Number participants (%) 20,554 (18.8) 33,512 (30.7) 24,666 (22.6) 17,274 (15.8) 13,261 (12.1)
Mean
Age (years) 34.6 34.0 34.1 34.3 34.7
Total caloric intake in high school (kilocalories)a 2737 2746 2745 2746 2781
Animal fat intake in high school (% energy)a 26.0 25.7 25.8 25.9 26.2
Vegetable fat intake in high school (% energy)a 14.4 14.7 14.8 15.0 15.0
Age at menarche (years) 12.8 12.6 12.3 12.1 12.0
Height (inches) 64.9 64.9 64.8 64.8 65.0
BMI at age 18 years (kg/m2) 19.3 20.2 21.5 22.9 24.3
Current BMI (kg/m2) 22.0 22.7 24.4 26.1 27.1
Age at first birth (years)b 25.4 25.5 25.6 25.6 25.4
Parityb 2.1 2.1 2.1 2.1 2.0
Percentage
Birthweight ≥  8.5 lb 8.3 9.4 11.7 12.9 13.7
≥  3 years from menarche until regular menstrual cycles 19.5 18.5 17.7 17.9 19.6
Irregular menstrual cycles/no periods ages 18–22 years 9.7 9.0 8.8 10.2 11.2
Menstrual cycle length ≥  40 days ages 18–22 years 7.1 7.1 7.3 8.2 8.6
Strenuous activity 10–12 months/year in high school 28.7 28.0 26.2 21.4 17.6
BMI at age 18 years ≥  25 kg/m2 1.8 3.1 8.9 19.5 32.2
Current BMI ≥  30 kg/m2 3.0 4.9 11.2 20.2 24.6
Nulliparous 29.6 29.2 29.3 31.3 35.0
Current oral contraceptive user 13.8 14.0 12.6 12.7 11.6
Current smoker 13.1 11.5 12.3 14.2 18.6
Alcohol consumption ≥  10 g/day 9.7 9.0 9.1 9.1 9.9
First-degree family history of breast cancer 5.9 6.0 5.7 5.9 6.3
History of benign breast disease 30.3 28.1 27.6 27.5 28.0
All means and percentages refer to the 1989 time period unless otherwise noted. Participants who had a diagnosis of cancer (other than 
nonmelanoma skin cancer) and those for whom body fatness data were missing at ages 5, 10, or 20 years were excluded. aAmong participants 
who completed the high school diet questionnaire in 1998. bAmong participants who reported that they were parous in 1989. BMI, body mass 
index.Available online http://breast-cancer-research.com/content/7/3/R314
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Table 2
Relative risks of breast cancer by body fatness at ages 5, 10, and 20 years, and during childhood and adolescence among 109,267 
premenopausal Nurses' Health Study II participants (1989–2001)
Casesa (n = 1318) Person-years Age-adjusted RR (95% CI) Multivariate RR (95% CI)b
Figure at age 5 years
1 350 252,779 1.00 (ref.) 1.00 (ref.)
2 431 335,974 0.97 (0.84–1.11) 0.96 (0.83–1.11)
3 304 251,625 0.89 (0.76–1.04) 0.88 (0.76–1.03)
4 173 133,574 0.94 (0.78–1.13) 0.93 (0.77–1.12)
≥  5 60 70,740 0.59 (0.45–0.78) 0.57 (0.43–0.75)
P for trendc 0.002 0.001
Figure at age 10 years
1 277 191,720 1.00 (ref.) 1.00 (ref.)
2 423 323,197 0.95 (0.82–1.11) 0.96 (0.82–1.11)
3 307 239,185 0.92 (0.79–1.09) 0.93 (0.79–1.10)
4 197 165,957 0.84 (0.70–1.01) 0.84 (0.70–1.01)
≥  5 114 124,633 0.62 (0.50–0.77) 0.61 (0.49–0.76)
P for trendc <0.0001 <0.0001
Figure at age 20 years
1 73 44,399 1.00 (ref.) 1.00 (ref.)
2 414 271,292 1.04 (0.81–1.33) 1.05 (0.82–1.35)
3 474 397,651 0.85 (0.67–1.09) 0.87 (0.68–1.11)
4 247 219,136 0.81 (0.62–1.05) 0.81 (0.63–1.06)
≥  5 110 112,213 0.71 (0.53–0.95) 0.70 (0.52–0.94)
P for trendc <0.0001 <0.0001
Average childhood figure (ages 5–10 years)
1 262 177,512 1.00 (ref.) 1.00 (ref.)
1.5–2 416 322,714 0.92 (0.79–1.08) 0.93 (0.79–1.08)
2.5–3 339 265,111 0.90 (0.77–1.06) 0.90 (0.76–1.06)
3.5–4.5 253 215,175 0.82 (0.69–0.97) 0.81 (0.68–0.96)
≥  5 48 64,180 0.49 (0.36–0.67) 0.48 (0.35–0.65)
P for trendc <0.0001 <0.0001Breast Cancer Research    Vol 7 No 3    Baer et al.
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were also included in the same multivariate model, to examine
the estimates mutually adjusted for one another. Height was
included as a continuous term in all multivariate models,
because it is positively associated with breast cancer inci-
dence [1] and may reflect nutritional status during childhood
[30].
To determine whether body fatness at young ages may have
an impact on breast cancer risk by altering characteristics of
the menstrual cycle, we first adjusted for age at menarche and
years from menarche until the onset of regular menstrual
cycles, because greater body fatness at young ages has been
associated with earlier menarche but longer time until the
establishment of regular cycles [31]. In addition, we consid-
ered adjustment for regularity and length of cycles during sev-
eral different time periods: high school, ages 18–22 years, and
recent (reported only once in 1993). With the exception of age
at menarche, which was modeled as a continuous variable,
indicator variables were used to represent categories of men-
strual cycle characteristics.
After conducting these analyses in the full sample, we then
restricted them to certain subgroups of participants: women
who had had at least one screening mammography during the
follow-up period (n = 89,129; 1223 cases), women who had
no reports of infertility (n = 82,892; 991 cases), and women
who had no history of irregular menstrual cycles (n = 51,909;
666 cases). This was done to explore further whether differen-
tial screening or anovulation could account for associations
between body fatness at young ages and premenopausal
breast cancer incidence. The 1044 invasive cases were also
examined in separate models and further stratified by tumor
size (574 cases <2 cm; 321 cases ≥  2 cm) and hormone
receptor status (604 estrogen receptor positive cases; 252
estrogen receptor negative cases; 571 progesterone receptor
positive cases; 267 estrogen receptor negative cases) when
this information was available.
We also examined whether associations for childhood fatness
varied according to family history of breast cancer (yes, no),
age at menarche (<12 years, ≥  12 years), parity (nulliparous,
parous), oral contraceptive use (never or past use <4 years,
past use ≥  4 years, or current use), birthweight (<7 lb, ≥  7 lb),
BMI at age 18 years (<22 kg/m2, ≥  22 kg/m2), or current BMI
(<25 kg/m2, ≥  25 kg/m2). Separate models were constructed
within each level of these factors to obtain stratum-specific
estimates, and interaction terms were created by multiplying
childhood body fatness as an ordinal variable by the level of
each potential modifier. Wald tests were then used to evaluate
whether the trends for body fatness were significantly different
according to these factors.
Results
The 109,267 premenopausal women in the analytic cohort
contributed a total of 1,044,691 person-years of follow-up.
Fatness levels at each of these ages were positively correlated
with one another and with BMI at age 18 years and in 1989,
although the correlations decreased with time. For example,
the Spearman correlation between figures at ages 5 and 10
years was 0.81, whereas the correlation between figure at age
5 years and BMI in 1989 was only 0.25. Body fatness at young
ages was also associated with other characteristics (Table 1).
Women who were fatter at age 10 years were heavier at birth,
had earlier menarche, had higher caloric intake and were less
likely to have participated in strenuous physical activity during
adolescence, and in later life they were more likely to be nul-
liparous and to smoke. A greater proportion of participants in
both the lowest and highest categories of body fatness at age
10 years reported 3 or more years from menarche until the
onset of regular menstrual cycles, whereas those in the high-
Average adolescent figure (ages 10–20 years)
1 56 34,780 1.00 (ref.) 1.00 (ref.)
1.5–2 398 267,086 1.07 (0.81–1.41) 1.08 (0.82–1.43)
2.5–3 449 366,516 0.92 (0.69–1.21) 0.93 (0.71–1.24)
3.5–4.5 363 312,070 0.85 (0.64–1.13) 0.86 (0.65–1.14)
≥  5 52 64,240 0.58 (0.40–0.85) 0.57 (0.39–0.83)
P for trendc <0.0001 <0.0001
aIncluding both invasive and in situ cases. bAdjusted for age (months), time period (6 periods), birthweight (<5.5, 5.5–6.9, 7–8.4, 8.5–9.9, ≥  10 
lb), height (inches), recent alcohol consumption (0, 0.1–1.4, 1.5–4.9, 5.0–9.9, ≥  10 g/day), parity and age at first birth (nulliparous, 1–2 
pregnancies with age at first birth <25 years, 1–2 pregnancies with age at first birth 25–29 years, 1–2 pregnancies with age at first birth ≥  30 
years, ≥  3 pregnancies with age at first birth <25 years, ≥  3 pregnancies with age at first birth 25–29 years, ≥  3 pregnancies with age at first birth 
≥  30 years), oral contraceptive use (never, past use <4 years, past use ≥  4 years, current use <4 years, current use ≥  4 years), history of benign 
breast disease (yes, no), and first-degree family history of breast cancer (yes, no). cWald test of coefficient for body fatness modeled as an ordinal 
variable. CI, confidence interval; RR, relative risk.
Table 2 (Continued)
Relative risks of breast cancer by body fatness at ages 5, 10, and 20 years, and during childhood and adolescence among 109,267 
premenopausal Nurses' Health Study II participants (1989–2001)Available online http://breast-cancer-research.com/content/7/3/R314
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est category were slightly more likely to have had irregular or
long cycles between ages 18 and 22 years.
Body fatness at ages 5, 10, and 20 years were each inversely
associated with premenopausal breast cancer risk (Table 2).
The multivariate RRs for the most overweight (figure level ≥  5)
compared with the most lean (figure level 1) were 0.57 (95%
CI 0.43–0.75; P for trend = 0.001) for age 5 years, 0.61 (95%
CI 0.49–0.76; P for trend < 0.0001) for age 10 years, and
0.70 (95% CI 0.52–0.94; P for trend < 0.0001) for age 20
years, after adjustment for age and time period, birthweight,
height, recent alcohol consumption, parity and age at first
birth, recency and duration of oral contraceptive use, history of
benign breast disease, and family history of breast cancer. The
associations of average childhood and adolescent body fat-
ness with breast cancer incidence were slightly stronger than
the associations at individual ages (Table 3), with multivariate
RRs of 0.48 (95% CI 0.35–0.65) and 0.57 (95% CI 0.39–
0.83) for the most overweight compared with the most lean in
childhood and adolescence, respectively (P  for trend <
0.0001). Additional adjustment for adolescent intakes of ani-
mal fat, vegetable fat, and vitamin E [32,33] among those par-
ticipants who completed the high school diet questionnaire,
physical activity during adolescence and adulthood, and
recent smoking did not materially change the RRs.
Increases in body fatness during childhood and adolescence
were also inversely associated with breast cancer risk (Table
3). Compared with participants who stayed at the same level
from age 5 to age 20 years, the multivariate RR for those who
increased 2 or more levels was 0.86 (95% CI 0.74–1.02).
This association became stronger after adjustment for body
fatness at age 5 years, with a multivariate RR of 0.77 (95% CI
0.65–0.91) for those who increased 2 or more levels. Similar
patterns were observed for changes in body fatness from ages
5 to 10 years and from ages 10 to 20 years.
We then evaluated whether the inverse association for child-
hood body fatness was independent of later BMI and men-
strual cycle characteristics (Table 4). When average
childhood body fatness was adjusted for the cumulative aver-
age of BMI at age 18 years and subsequent BMI, the associ-
ation was only slightly attenuated; the multivariate RR was
0.52 (95% CI 0.38–0.71) for the most overweight compared
Table 3
Relative risks of breast cancer by changes in body fatness between ages 5, 10, and 20 years among 109,267 premenopausal Nurses' 
Health Study II participants (1989–2001)
Casesa (n = 1318) Person-years Age-adjusted RR (95% CI) Multivariate RR (95% CI)b Multivariate RR + starting figurec
Change from ages 5 to 10 years
Decreased 76 59,972 0.97 (0.77–1.23) 0.94 (0.74–1.19) 1.04 (0.82–1.32)
No change 950 720,994 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Increased 1 level 218 194,725 0.87 (0.75–1.01) 0.88 (0.76–1.02) 0.88 (0.76–1.02)
Increased 2 or more levels 74 69,001 0.79 (0.62–1.00) 0.79 (0.62–1.00) 0.77 (0.61–0.98)
Change from ages 10 to 20 years
Decreased 223 184,978 0.86 (0.74–1.01) 0.86 (0.74–1.01) 1.06 (0.89–1.27)
No change 497 353,987 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Increased 1 level 463 388,462 0.92 (0.81–1.04) 0.92 (0.81–1.05) 0.85 (0.74–0.97)
Increased 2 or more levels 135 117,264 0.93 (0.77–1.12) 0.92 (0.76–1.11) 0.82 (0.67–0.99)
Change from ages 5 to 20 years
Decreased 172 135,479 0.91 (0.76–1.08) 0.90 (0.75–1.07) 1.06 (0.88–1.29)
No change 449 321,121 1.00 (ref.) 1.00 (ref.) 1.00 (ref.)
Increased 1 level 474 384,088 0.94 (0.83–1.08) 0.95 (0.83–1.08) 0.88 (0.77–1.01)
Increased 2 or more levels 223 204,003 0.87 (0.74–1.02) 0.86 (0.74–1.02) 0.77 (0.65–0.91)
aIncluding both invasive and in situ cases. bAdjusted for age (months), time period (6 periods), birthweight (<5.5, 5.5–6.9, 7–8.4, 8.5–9.9, ≥  10 lb), 
height (inches), recent alcohol consumption (0, 0.1–1.4, 1.5–4.9, 5.0–9.9, ≥  10 g/day), parity and age at first birth (nulliparous, 1–2 pregnancies 
with age at first birth <25 years, 1–2 pregnancies with age at first birth 25–29 years, 1–2 pregnancies with age at first birth ≥  30 years, ≥  3 
pregnancies with age at first birth <25 years, ≥  3 pregnancies with age at first birth 25–29 years, ≥  3 pregnancies with age at first birth ≥  30 years), 
oral contraceptive use (never, past use <4 years, past use ≥  4 years, current use <4 years, current use ≥  4 years), history of benign breast disease 
(yes, no), and first-degree family history of breast cancer (yes, no). cAdjusted for same factors as above, plus figure at age 5 years (for change from 
ages 5 to 10 years and from ages 5 to 20 years) or at age 10 years (for change from ages 10 to 20 years), each modeled as an ordinal variable. CI, 
confidence interval; RR, relative risk.Breast Cancer Research    Vol 7 No 3    Baer et al.
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with the most lean (P for trend = 0.001). The results were sim-
ilar when childhood body fatness was adjusted for BMI at age
18 years and current BMI separately. Adjustment for menstrual
cycle characteristics had virtually no impact on the association
for childhood body fatness. Furthermore, when the analyses
were restricted to participants who reported having regular
menstrual cycles during both adolescence and adulthood, and
to participants with no reports of infertility, the multivariate RRs
for childhood body fatness were almost identical to those in
the full sample (data not shown).
In separate models in which BMI at age 18 years and current
BMI were adjusted for childhood body fatness, each remained
inversely related to breast cancer incidence, although the
associations were attenuated and less strong than the associ-
ation for childhood body fatness. The multivariate RRs for the
highest versus the lowest categories of BMI at age 18 years
and current BMI, adjusted for childhood body fatness, were
0.84 (95% CI 0.66–1.07) and 0.86 (95% CI 0.71–1.04),
respectively. When average childhood body fatness and body
fatness at age 20 years were included in the same model as
indicator variables, the multivariate RR for the most overweight
compared with the most lean in childhood was 0.56 (95% CI
0.40–0.78; P for trend = 0.03), whereas the multivariate RR
for the most overweight compared with the most lean at age
20 years was 0.82 (95% CI 0.59–1.14; P for trend = 0.02).
The associations for childhood and adolescent body fatness
were slightly stronger in the analyses including only invasive
cases. The multivariate RR for the most overweight compared
with the most lean during childhood was 0.45 (95% CI 0.31–
0.64; P for trend < 0.0001) and during adolescence was 0.52
(95% CI 0.33–0.80; P for trend < 0.0001). The decreased
risk was apparent both for small and large tumors and for
hormone receptor positive and negative tumors (data not
shown), although some of the estimates were imprecise
because of small numbers of cases. The associations were
also very similar among the subgroup of women who had had
at least one screening mammography during the follow-up
period (data not shown).
The observed associations for childhood body fatness did not
differ appreciably by family history of breast cancer, age at
menarche, parity, oral contraceptive use, or birthweight (data
not shown). The inverse trend across categories of childhood
body fatness was somewhat more apparent among those who
were heavy than among those who were lean at age 18 years,
and the test for interaction was marginally significant (χ 2 
1 =
Table 4
Relative risks for breast cancer by average childhood body fatness, with adjustment for later body mass index and menstrual cycle 
characteristics, among 109,267 premenopausal Nurses' Health Study II participants (1989–2001)
Average childhood figure (ages 5–10 years) P for trendd
1 1.5–2 2.5–3 3.5–4.5 ≥  5
Multivariate RR (95% CI)a 1.00 0.93 (0.79–1.08) 0.90 (0.76–1.06) 0.81 (0.68–0.96) 0.48 (0.35–0.65) <0.0001
Multivariate RR + later BMIb
BMI at age 18 years 1.00 0.95 (0.81–1.11) 0.95 (0.80–1.12) 0.87 (0.72–1.05) 0.53 (0.38–0.73) 0.004
Current BMI 1.00 0.93 (0.80–1.09) 0.92 (0.78–1.08) 0.84 (0.70–1.01) 0.51 (0.37–0.69) 0.0003
Cumulatively averaged BMI 1.00 0.94 (0.81–1.10) 0.93 (0.79–1.10) 0.86 (0.72–1.03) 0.52 (0.38–0.71) 0.001
Multivariate RR + age at menarche and menstrual cycle characteristicsc
Age at menarche 1.00 0.93 (0.80–1.09) 0.89 (0.76–1.05) 0.80 (0.67–0.95) 0.47 (0.34–0.64) <0.0001
Age at menarche, time until regular cycles 1.00 0.93 (0.80–1.09) 0.89 (0.76–1.05) 0.80 (0.67–0.95) 0.47 (0.34–0.64) <0.0001
Age at menarche, regularity/length of cycles, 
ages 18–22 years
1.00 0.93 (0.80–1.09) 0.89 (0.76–1.05) 0.79 (0.67–0.95) 0.47 (0.34–0.64) <0.0001
aAdjusted for age (months), time period (6 periods), birthweight (<5.5, 5.5–6.9, 7–8.4, 8.5–9.9, ≥  10 lb), height (inches), recent alcohol 
consumption (0, 0.1–1.4, 1.5–4.9, 5.0–9.9, ≥  10 g/day), parity and age at first birth (nulliparous, 1–2 pregnancies with age at first birth <25 years, 
1–2 pregnancies with age at first birth 25–29 years, 1–2 pregnancies with age at first birth ≥  30 years, ≥  3 pregnancies with age at first birth <25 
years, ≥  3 pregnancies with age at first birth 25–29 years, ≥  3 pregnancies with age at first birth ≥  30 years), oral contraceptive use (never, past use 
<4 years, past use ≥  4 years, current use <4 years, current use ≥  4 years), history of benign breast disease (yes, no), and first-degree family history 
of breast cancer (yes, no). bAdjusted for same factors as above, plus later body mass index (BMI) variables individually, each modeled as medians of 
the categories. Cumulatively-averaged BMI is the cumulative average of BMI at age 18 years and all subsequent BMI reports up until the current 
time period. cAdjusted for same factors as above (not including later BMI), plus menstrual cycle characteristics. Age at menarche modeled as 
continuous. Time until onset of regular cycles (<1 year, 1–2 years, ≥  3 years, never) and cycle regularity and length from ages 18–22 years (regular 
<26 days, regular 26–31 days, regular ≥  32 days, irregular <26 days, irregular 26–31 days, irregular ≥  32 days) modeled as indicator variables. 
dWald test of coefficient for body fatness modeled as an ordinal variable. CI, confidence interval; RR, relative risk.Available online http://breast-cancer-research.com/content/7/3/R314
R322
3.68; P = 0.06), although the multivariate RRs for the most
overweight compared with the most lean in childhood were
very similar in both categories of BMI at age 18 years (RR =
0.42 among those with BMI <22 kg/m2 at age 18 years, P for
trend = 0.08; and RR = 0.49 among those with BMI ≥  22 kg/
m2 at age 18 years, P for trend = 0.001). In contrast, the asso-
ciation for childhood body fatness did not differ according to
current BMI (data not shown).
Discussion
In this prospective study we observed a significant inverse
association between body fatness during childhood and ado-
lescence and incidence of breast cancer in premenopausal
women, with approximately 50% lower risk for the most over-
weight compared with the most lean in childhood. The magni-
tude of the decrease in risk was greater for childhood body
fatness than for body fatness at older ages. The inverse asso-
ciation was independent of later BMI and menstrual cycle
characteristics, suggesting that body fatness at young ages
may influence breast cancer risk through other biologic
pathways.
Our findings are consistent with the results of some other
studies that have examined this relationship. Le Marchand and
colleagues [12] linked prospectively recorded information on
height and weight from census data for over 38,000 women to
the Hawaii Tumor Registry, from which 607 cases of breast
cancer were identified. In that study BMI at ages 5–9 years,
10–14 years, and 20–24 years were each inversely associ-
ated with breast cancer incidence, but the strongest
association was for BMI from ages 10–14 years, with an odds
ratio of 0.51 for the highest versus the lowest tertile. A second
prospective study of 3447 women born at the University Hos-
pital of Helsinki [13] obtained anthropometric measurements
from birth and school health records and linked this informa-
tion to the National Hospital Discharge Registry and the
Cause of Death registry, identifying 177 incident cases of
breast cancer. BMI at ages 7–15 years were inversely associ-
ated with breast cancer risk, with a RR of 0.83 for each 1 kg/
m2 increase in BMI at age 7 years. Both studies, however,
lacked information on other important breast cancer risk fac-
tors that might confound these associations. In a prospective
cohort study conducted in Norway and Sweden [15], the
investigators observed inverse associations of perceived body
shape at age 7 years and BMI at age 18 years with incidence
of premenopausal breast cancer, with approximately 30%
decreased risk for those who were fat or very fat at age 7 years
compared with those who were average. In contrast to our
findings, the association was strongest for adult BMI at enroll-
ment, and the associations for perceived body shape at age 7
years and BMI at age 18 years were no longer significant after
this adjustment. However, only 733 cases were included in
that study, which could explain the lack of significance. A
recent record linkage study conducted in Denmark that
included over 3000 breast cancer cases [16] also observed a
modest inverse association for BMI at age 14 years, based on
information from school health records, but data on adult BMI
were not available.
Other epidemiologic studies have assessed body fatness at
young ages through recall. Most of these utilized a case-con-
trol design in which women with breast cancer and cancer-
free controls were asked to categorize their relative weight
compared with other girls at specific ages. The majority found
inverse associations for body fatness during the childhood and
teenage years, observing a 30–50% decrease in risk for those
who reported being heavier or much heavier compared with
those who recalled being thin or average size [4,5,7,10]. Sev-
eral others [8,9,11], however, have not found such inverse
associations.
Two previous studies have assessed the relationship between
body fatness at young ages and breast cancer risk using the
same 9-level figure drawing as in our study. In a large Swedish
population-based case-control study of 3345 cases of inva-
sive breast cancer and 3454 controls between ages 50 and
74 years [6], body fatness at ages 7 and 18 years were both
inversely associated with postmenopausal breast cancer risk,
with a RR of 0.38 for figure level 7 or greater versus level 4 at
age 7 years. In a largely retrospective analysis within the earlier
Nurses' Health Study [14], body fatness at ages 5, 10, and 20
years were each inversely associated with risk of premenopau-
sal breast cancer, with the strongest association for age 10
years. When body fatness at these ages were mutually
adjusted for one another, the RR for figure level 5 or greater
compared with level 1 was 0.60 for body fatness at age 10
years. A similar pattern was also observed for postmenopausal
breast cancer.
Ours is one of the first prospective studies to examine the rela-
tion between childhood body fatness and breast cancer inci-
dence, and we were able to control for a broad range of
factors, both in early life and adulthood, that were not available
in earlier studies. In addition, unlike most previous studies, we
adjusted for later BMI using several different variables, includ-
ing the cumulative average of BMI at age 18 years and all sub-
sequent BMI reports to obtain the best long-term measure.
Even with this adjustment, the inverse associations for body
fatness during childhood and adolescence remained strong
and statistically significant, suggesting that greater body fat-
ness at early stages of life, perhaps even before puberty, may
lower breast cancer risk. In addition, in the analyses stratified
by current BMI, greater childhood body fatness was associ-
ated with reduced risk of breast cancer among both lean and
heavy women, which indicates that greater childhood body fat-
ness may confer a lasting protective effect. The biologic mech-
anisms that would explain this, however, are not well
understood. One theory postulates that more overweight girls
may experience slower pubertal growth and sexual maturation,
despite their earlier menarche [6,14]. In the HarvardBreast Cancer Research    Vol 7 No 3    Baer et al.
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Longitudinal Study of Child Health and Development [34],
leaner body mass at age 10 years was predictive of more rapid
adolescent growth, and in the Nurses' Health Study [14] ado-
lescents in the highest two quintiles of estimated growth rate
had nearly 50% increased risk of premenopausal breast can-
cer. Rapid adolescent growth may increase breast cancer risk
by increasing levels of growth hormones and epithelial prolif-
eration in the breast or by decreasing the amount of time for
repair of DNA damage [19].
The effect of body fatness at young ages may also be medi-
ated through hormonal pathways. Obesity in pre-adolescent
and adolescent girls is associated with higher basal insulin lev-
els [35,36], which can impair oocyte maturation and stimulate
androgen production in the ovary [31,37]. Hyperinsulinemia is
also associated with decreased plasma levels of sex hormone
binding globulin, leading to increases in free (unbound) testo-
sterone and estradiol, and the aromatization of excess
androgen to estrogen in adipose tissue may also increase
estrogen levels [38]. Greater waist:hip ratio has been associ-
ated with higher serum concentrations of testosterone and
estradiol in prepubertal and pubertal girls in some studies
[31,39] but not all studies [40,41]. High levels of androgens in
adolescent girls are associated with metabolic features of
polycystic ovary syndrome [42], greater frequency of anovula-
tory cycles [37], and reduced fertility later in life [43]. In a pre-
vious study conducted among participants in this cohort [44],
higher BMI at age 18 years was associated with increased risk
of irregular and long menstrual cycles between ages 18 and
22 years as well as increased risk of ovulatory infertility in
adulthood [44], and greater body fatness at age 10 years was
also associated with moderately increased risk of menstrual
cycle irregularities and nulliparity in the present analysis after
adjustment for other factors. In addition, menstrual cycle regu-
larity and length were related to breast cancer risk among
NHS II participants during the first few years of follow up [45].
However, the observed associations for body fatness at young
ages in the present study were nearly identical among partici-
pants with no history of irregular menstrual cycles or infertility,
suggesting that these are not intermediate factors and that
other mechanisms may be involved.
High levels of sex hormones in overweight prepubertal and
pubertal girls may also have a more direct protective effect on
breast tissue. Several experiments have shown that neonatal,
prepubertal, or pubertal administration of estrogen, prolactin,
progesterone, or testosterone in rats leads to differentiation of
cells of the mammary gland as well as a substantial reduction
in the incidence of mammary tumors following exposure to
chemical carcinogens [46-50]. Hence, some have recently
hypothesized that the timing of exposure to estrogens and
other hormones may determine their effects on breast tissue
[51,52]. Hilakivi-Clarke [51] has suggested that early estrogen
exposure may reduce breast cancer risk by increasing the
expression of tumor suppressor genes such as BRCA1,
inducing differentiation of immature breast cells into more
mature ductal structures in addition to stimulating epithelial
growth. Higher levels of estrogens may be protective in the
breasts of young girls, which are less likely to contain malig-
nant cells, but harmful in older women, whose breasts are
more likely to have acquired transformed cells.
Of course, alternative explanations for our findings cannot be
ruled out entirely. Although two well designed validation stud-
ies [25,29] demonstrated that long-term recall of body fatness
using this figure drawing has high correlations with BMI at the
same ages, no participants in either of those studies recalled
their figure as greater than level 7 at young ages; hence, the
accuracy of recall at the highest levels of body fatness could
not be assessed. Furthermore, the validation studies showed
that women who were obese had a greater tendency to under-
estimate their body fatness at young ages than those who
were lean, which could exaggerate the observed association
for less extreme levels of body fatness. However, this would
not explain the overall association, and the decreasing trend
that we observed in age at menarche across all levels of body
fatness at age 10 years is strong evidence of the validity of our
assessment. We also repeated the analyses using the middle
category of body fatness at each age and during childhood
and adolescence as the referent group, to evaluate whether
the observed inverse association could possibly be explained
by higher risk among participants who were extremely lean at
young ages. When we did this, we still observed significantly
lower risk for the most overweight compared with the middle
category. For example, for average childhood body fatness,
the multivariate RR for the most overweight compared with the
middle category (level 2.5–3) was 0.53 (95% CI 0.39–0.72),
whereas the multivariate RR for the most lean was 1.11 (95%
CI 0.95–1.31); this argues against elevated risk among the
most lean as the major explanation for our findings. Other
unmeasured factors, especially those during early life and
childhood, could also confound the associations for body fat-
ness at young ages, although a confounder would have to be
very strong to account for an association of this magnitude.
Detection bias is another possibility because women who are
obese as adults may be less likely to get regular screening
mammograms [53], which could delay or reduce the chance
of detection. In this population, however, the probability of hav-
ing a screening mammography was not appreciably related to
childhood body fatness or current BMI among women in sev-
eral age groups. For example, among women ages 50–54
years in 1999, 69.2% of those who were figure level 1 at age
10 years reported having had a screening mammogram within
the preceding 2 years, as compared with 71.8% of those who
were figure level 5 or greater at age 10 years. These percent-
ages were similar when examined according to current BMI in
1999 among women ages 50–54 years, although a slightly
greater proportion of those in the intermediate category of BMI
(23–24.9 kg/m2) reported having had a recent screeningAvailable online http://breast-cancer-research.com/content/7/3/R314
R324
mammogram compared with those in either of the two extreme
categories (74.4% compared with 69.6% for those with BMI
<21 kg/m2 and 69.0% for those with BMI ≥  30 kg/m2). We still
observed a strong inverse association between early body fat-
ness and breast cancer risk among women who reported hav-
ing at least one screening mammography. In addition, if easier
detection in lean women were the main explanation for our
findings, we would have expected the association to become
weaker when in situ cases were excluded, which is not what
occurred. The results stratified by tumor size showed an
inverse association for both large and small tumors, also argu-
ing against a detection bias.
Conclusion
These data indicate that greater body fatness during child-
hood and adolescence may reduce the incidence of premen-
opausal breast cancer, independently of adult BMI and
menstrual cycle characteristics, and that this association may
be stronger than the association for BMI at later ages. These
findings should be interpreted cautiously, given that greater
adiposity in adolescence has numerous adverse long-term
health consequences [54] and that obesity in postmenopausal
women increases breast cancer risk [3]. However, they could
help to elucidate the biologic mechanisms that are involved in
the etiology of breast cancer. In light of the strength of our find-
ings and their consistency with those of previous studies, iden-
tifying causal pathways that would help explain this inverse
association should be a priority for future research.
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